Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth

Hepatology. 2004 Jan;39(1):90-6. doi: 10.1002/hep.20030.

Abstract

Long-term follow up studies of hepatitis C virus (HCV) infection rarely exceed 20-25 yr. We studied the outcome of HCV infection in 35-yr-old adults infected at birth (1968) through mini transfusions of blood. A retrospective-prospective study was carried out. The cohort included 31 individuals who were given mini blood transfusions (21-30 ml) collected from a donor subsequently revealed to be HCV infected. At enrollment (1998), 18 of 31 (58.1%) recipients had anti-HCV antibody and 16 (88.9%) of them were HCV-RNA positive. All viremic recipients and the infectious donor had the same genotype 1b. Sequence analysis of E1/E2 and NS5b regions, coupled with phylogenetic analysis, indicated that HCV isolates from donor/recipients were linked. Eleven of the 16 viremic recipients gave consent to liver biopsy. Nine had no fibrosis or mild portal fibrosis and 2 had either discrete (Ishak's staging 3) or marked (Ishak's staging 4) fibrosis. During the prospective follow-up period (1998-2003), 2 patients were given therapy, one of whom achieved sustained clinical and virologic response. A second biopsy, performed in 5 patients at a 5 yr interval, revealed no substantial modifications in 4 cases and progression from absence of fibrosis to mild portal fibrosis in the fifth. In conclusion, taking into account the limited study sample, these findings suggest that HCV infection acquired early in life shows a slow progression and mild outcome during the first 35 yr of infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biopsy
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Hepacivirus / genetics*
  • Hepacivirus / immunology
  • Hepatitis C Antibodies / blood
  • Hepatitis C, Chronic / pathology*
  • Hepatitis C, Chronic / transmission*
  • Humans
  • Infant, Newborn
  • Male
  • Phylogeny
  • Retrospective Studies
  • Time Factors
  • Transfusion Reaction*

Substances

  • Hepatitis C Antibodies